Plandai Biotechnology Inc (PLPL)

[TheFinalCD]

Protext Pharma, Inc. (F.K.A. Protext Mobility), operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (PTY) LTD. and Cannabis Biosciences, Inc. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Plandai Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Phytofare Catechin Complex, has been clinically shown to have 10x greater bioavailability over generic catechin extracts. Cannabis Biosciences has developed a proprietary processing and extraction technology that utilizes live plant for producing a full-profile cannabis extract, that contains the precursor acid form of THC (THC-A and THC-B) found in live cannabis plant. The Company has conducted in investigations in SA which has shown that the Cannabis Biosciences extraction process, using live plant material and low temperatures to extract the phyto-chemicals, leaves the acid forms of THC intact.
https://www.otcmarkets.com/stock/TXTM/profile